Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oxford BioDynamics ( (GB:OBD) ) has provided an announcement.
Oxford BioDynamics PLC has reported a change in the shareholding structure, with Cantor Fitzgerald Europe reducing its voting rights from 5.912% to 2.0525%. This change indicates a shift in the financial instruments held, potentially impacting the company’s market perception and stakeholder confidence.
More about Oxford BioDynamics
Oxford BioDynamics PLC operates in the biotechnology industry, focusing on the development of epigenetic biomarkers for use in personalized medicine. The company’s primary products are diagnostic tests and tools that aim to improve patient outcomes and healthcare efficiency.
YTD Price Performance: -66.80%
Average Trading Volume: 9,241,488
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £9.75M
See more insights into OBD stock on TipRanks’ Stock Analysis page.